IBO 25-NSE: Delisting notice

Filed with the SEC on · accession 0001143313-26-000059

IBO filed a 25-NSE (25-nse) with the SEC on Nov 18, 2026. NYSE American notified the SEC of its intent to remove Impact BioMedical Inc.'s common stock from listing and registration effective November 30, 2026, following the completion of its merger with Zoar Limited on November 17, 2026.

Summary of the filing

NYSE American notified the SEC of its intent to remove Impact BioMedical Inc.'s common stock from listing and registration effective November 30, 2026, following the completion of its merger with Zoar Limited on November 17, 2026. Each share of Impact BioMedical common stock was converted into Zoar Limited shares representing 4.80% of the total issued and outstanding PubCo shares, and trading was suspended on November 18, 2026.

Key details

Percentage of total issued and outstanding PubCo shares received per Impact BioMedical share in the merger$5
Subject company being delistedImpact BioMedical Inc.
Exchange filing the delisting noticeNYSE American LLC
Acquiring company in the mergerZoar Limited (f.k.a. Dr Ashleys Limited)
Analyst, market watch, nyse american llcAnthony Sozzi

✦ Ask GOAX AI about this filing — what it means for IBO, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for IBO?

Click here

Frequently asked questions

What did IBO file with the SEC on Nov 18, 2026?

IBO filed a 25-NSE (Delisting notice). NYSE American notified the SEC of its intent to remove Impact BioMedical Inc.'s common stock from listing and registration effective November 30, 2026, following the completion of its merger with Zoar Limited on November 17, 2026. Each share of Impact BioMedical common stock was converted into Zoar Limited shares representing 4.80% of the total issued and outstanding PubCo shares, and trading was suspended on November 18, 2026.

What does a delisting notice mean for IBO stock?

The stock often falls sharply. In a Chapter 11 reorganization existing shares are frequently cancelled or heavily diluted; in Chapter 7 the company is liquidated and shareholders are paid last, usually nothing.

How do I read a 25-NSE?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 25-NSE (25-nse): A report the company filed with the SEC (the US market regulator).

Other IBO SEC filings

Get alerts when IBO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days